Secop’s new dedicated range of compressors is optimized for the safe storage, transport, and handling of highly sensitive substances including pharmaceuticals, vaccines, cells, genes, blood, etc. The reliability of cooling equipment is essential to ensure the quality and usability of stored assets.
Secop now provides a solution with several benefits such as enhanced robustness, ultra-low temperature technology, and compatibility with refrigerant Ethan (R170) with its new medical compressors range. This makes them the ideal solution for hospitals, laboratories, pharmacies, research centers, universities, and the medical industry.
The medical and vaccine cold chain requires storage and transport at different temperature levels: +2°C to +8°C, -20°C down to -86°C. Stability is key to guarantee safe product delivery up to the last mile temperature.
New highly effective mRNA-based vaccines supporting the fight against COVID-19, and Ebola, or CGTs (cell and gene therapies) require an ultra-low storage and transportation temperature for all phases of the cold chain. Our stationary and mobile solutions make us a reliable partner for leading companies supporting the development of a global ULT (ultra-low temperature) supply chain.
Our compressor and control electronic solutions are used in different applications which are officially certified by WHO (World Health Organization) to support global access to vaccines. With the SDD (Solar Direct Drive) solution, we are able to support the distribution of vaccines in regions with a limited electricity grid, even in severe ambient conditions. Secop's solution is the only one used in WHO certified vaccine refrigerators.
MP2UVULTM – Ultra-Low Temperature Mobile Medical Cooling
Secop has developed the technology for an ultra-low temperature mobile cooling system. This system is optimized for the last mile of distribution for the new generations of vaccines and offers mobile operation even in high ambient conditions such as in tropical regions. This solution with a MP2UVULTM compressor takes advantage of Secop’s experience in medical applications, vaccine solar freezers, and mobile solutions and combines all of these areas of use.
Battery-driven active cooling systems for mRNA-based vaccines provide a lot of advantages compared to existing passive cooling (dry ice) transport boxes. Active systems offer temperature control, do not need huge quantities of dry ice, are re-usable, do not waste tons of CO2, and prevent wasting vaccine.
They are suitable for any distribution point, including in remote areas where the availability of CO2 cannot be guaranteed or ambient conditions are severe.
MP2UVULTM – Benefits:
- Mobile solution which is able to reach -70°C to -86°C
- Ideal solution for mains volt. independent transport of mRNA-based COVID-19 vaccines
- Precise cooling and control of target temperature
- Perfect for vaccine transportation with temp. control and no risk of wasting vaccine
- Reliable long lasting systems with low TCO life cycle
- Optimized and proven design for robust transport boxes
- Electronically controlled variable-speed drive compressor
- Easy °CCD® (Cool Capacity Drive) controller customization via Tool4Cool®
Application NoteULT Freezer – Design Consideratons for Low Temperature Stages PDF download (53.63 kB)